[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100053688":3},{"organization":4,"armGroups":7,"interventions":8,"overallOfficials":7,"centralContacts":7,"locations":7,"responsibleParty":7,"collaborators":7,"id":16,"slug":17,"hasResults":18,"nctId":19,"briefTitle":20,"officialTitle":7,"acronym":7,"eligibilityCriteria":21,"healthyVolunteers":18,"sex":22,"minAge":23,"maxAge":7,"enrollmentInfo":7,"targetDuration":7,"studyType":24,"phases":25,"briefSummary":27,"conditions":28,"keywords":7,"overallStatus":32,"whyStopped":7,"lastUpdateSubmitDate":33,"lastUpdatePostDateStruct":34,"startDateStruct":37,"completionDateStruct":39,"leadSponsor":42,"locationsCount":7},{"fullName":5,"class":6},"National Heart, Lung, and Blood Institute (NHLBI)","NIH",null,[9,12,14],{"type":10,"name":11,"description":7,"armGroupLabels":7,"otherNames":7},"DRUG","prednisone",{"type":10,"name":13,"description":7,"armGroupLabels":7,"otherNames":7},"cyclophosphamide",{"type":10,"name":15,"description":7,"armGroupLabels":7,"otherNames":7},"dapsone","100053688","phase-2-diffuse-fibrotic-lung-disease-100053688",false,"NCT00000596","Diffuse Fibrotic Lung Disease","No eligibility criteria","ALL","18 Years","INTERVENTIONAL",[26],"PHASE2","To determine the effects of cyclophosphamide compared with prednisone, dapsone, or high-dose intermittent 'pulse' therapy with methylprednisolone in patients with idiopathic pulmonary fibrosis. Also, to evaluate the use of intermittent, short-term, high-dose intravenous corticosteroids in patients with sarcoidosis. There were actually four separate clinical trials.",[29,30,31],"Lung Diseases","Pulmonary Fibrosis","Sarcoidosis","COMPLETED","2013-11-25",{"date":35,"type":36},"2013-11-26","ESTIMATED",{"date":38,"type":7},"1978-06",{"date":40,"type":41},"1983-01","ACTUAL",{"name":5,"class":6}]